Hikma Launches Nasal Naloxone Spray In US

Emergency Opioid Overdose Treatment Approved Through 505(b)(2) Pathway

Nose Nasal Nostrils
Hikma has launched its Kloxxado naloxone nasal spray in the US • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin